Effect of captopril on radiation-induced TGF-?1 secretion in EA.Hy926 human umbilical vein endothelial cells.
Ontology highlight
ABSTRACT: The pathophysiological mechanism involved in the sustained endothelial secretion of cytokines that leads to fibrosis 6-16 months after radiotherapy remains unclear. Angiotensin II (Ang II) is produced by the endothelium in response to stressing stimuli, like radiation, and may induce the synthesis of TGF-?, a profibrotic cytokine. In this study we tested the hypothesis that captopril, an angiotensin-converting enzyme (ACE) inhibitor, inhibits or attenuates radiation-induced endothelial TGF-?1 secretion. The human endothelial hybrid cell line EA.HY926 was irradiated with split doses of x-rays (28 Gy delivered in 14 fractions of 2 Gy). TGF-?1 mRNA, TNF-? mRNA and TGF-?1 protein levels were evaluated by RT-PCR and western blotting each month until the fifth month post radiation. Ang II was detected using radioimmunoassays, NF-?B activity was examined using EMSA, and western blotting was used to detect the expression of I?-B?. To explore the role of Ang II on radiation-induced TGF-?1 release and I?-B? expression, captopril was added to cultured cells before, during, or after irradiation. Sustained strong expression of TGF-?1 was observed after conventional fractionated irradiation. TNF-?, Ang II, and NF-?B activity were also increased in EA.Hy926 cells after radiation. Captopril decreased Ang II expression, inhibited the NF-?B pathway and reduced TGF-?1 expression. These data suggest that captopril might protect the endothelium from radiation-induced injury.
SUBMITTER: Wei J
PROVIDER: S-EPMC5400550 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA